| Product NDC: | 59762-0531 |
| Proprietary Name: | Phenytoin |
| Non Proprietary Name: | PHENYTOIN |
| Active Ingredient(s): | 125 mg/5mL & nbsp; PHENYTOIN |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 59762-0531 |
| Labeler Name: | Greenstone LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA008762 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20121001 |
| Package NDC: | 59762-0531-1 |
| Package Description: | 237 mL in 1 BOTTLE (59762-0531-1) |
| NDC Code | 59762-0531-1 |
| Proprietary Name | Phenytoin |
| Package Description | 237 mL in 1 BOTTLE (59762-0531-1) |
| Product NDC | 59762-0531 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | PHENYTOIN |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20121001 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Greenstone LLC |
| Substance Name | PHENYTOIN |
| Strength Number | 125 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |